Rutherford Health plc sets up agreement with NHS SBS

Rutherford Health plc sets up agreement with NHS SBS

Press releases may be edited for formatting or style | May 26, 2020 Rad Oncology Proton Therapy
Rutherford Health plc is delighted to announce that it has entered into a framework agreement with NHS Shared Business Services (“NHS SBS”), under which it is able to provide cancer treatment services on demand by any NHS Trust at a pre-agreed set of prices.

The agreement lasts for two years with an option to extend for a further two years on the agreement of both parties. The agreement covers the complete range of services that Rutherford offers, including radiotherapy, systemic anti-cancer therapy (chemotherapy), proton beam therapy and diagnostic services.

NHS SBS was established by the Department of Health and Social Care (DHSC) in a unique partnership with digital experts Sopra Steria. NHS SBS delivers modern corporate services to the NHS, which improve efficiency and quality, save time and money, and support world-class patient care.

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

Mike Moran, Rutherford’s CEO commented: “We are absolutely delighted to have signed this agreement with NHS SBS. We have been supplying radiotherapy and systemic anti-cancer therapy to NHS patients in England and Wales and proton beam therapy to a small number of adult NHS patients in Wales under contracts with individual NHS Trusts. This agreement streamlines the procurement process and enables any NHS Trusts in England and Wales to order services directly from us. It means that we are now in a position to expand the services we actually provide.

“I am particularly delighted to be supporting the fantastic work that the NHS are doing at this incredibly difficult time by providing these critically needed cancer treatments and services in dedicated cancer treatment facilities, relieving the pressure on NHS hospitals”.

Phil Davies, Director of Procurement at NHS commented: “NHS organisations routinely acquire extra clinical capacity to deal with spikes in demand and to keep waiting lists down for patients. The recent extreme pressure on NHS services means that additional clinical support is likely to be needed now more than ever. We have worked with a number of NHS trusts to put a framework in place that enables any NHS provider to access high-quality clinical services quickly – in a cost-effective and compliant manner.”

You Must Be Logged In To Post A Comment